Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio Licenses Gene Mutation Patent to InVivoScribe Technologies

NEW YORK (GenomeWeb News) - Takara Bio has licensed to InVivoScribe Technologies its patent for detecting the mutations of FMS-like tyrosine kinase 3 genes, Takara Bio said today.
 
Under the agreement, InVivoScribe will receive an exclusive license to use the patent worldwide, except in Japan. The company will be allowed to develop, manufacture, and sell a reagent for detecting FLT3 gene mutations. It can also sublicense the patent to others.
 
InVivoScribe Technologies will make an upfront payment and royalties on sales and sublicenses to Takara Bio.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.